PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
52.55%
Net income growth at 50-75% of MRVL's 97.45%. Martin Whitman would worry about lagging competitiveness unless expansions are planned.
-0.55%
Negative yoy D&A while MRVL is 1.73%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-370.27%
Negative yoy deferred tax while MRVL stands at 0.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
No Data
No Data available this quarter, please select a different quarter.
83.87%
Well above MRVL's 61.66% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
100.00%
AR growth of 100.00% while MRVL is zero at 0.00%. Bruce Berkowitz would see a mild difference in credit approach that could matter for cash flow.
1333.33%
Inventory growth well above MRVL's 167.21%. Michael Burry would suspect potential future write-down risk if demand does not materialize.
-100.00%
Negative yoy AP while MRVL is 0.00%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
67.36%
Some yoy usage while MRVL is negative at -2137.87%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
1125.00%
Growth of 1125.00% while MRVL is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might reflect intangible expansions or partial write-offs.
58.13%
Operating cash flow growth at 50-75% of MRVL's 89.79%. Martin Whitman would worry about lagging operational liquidity vs. competitor.
7.22%
CapEx growth well above MRVL's 6.96%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
69.02%
Purchases well above MRVL's 56.81%. Michael Burry would see major cash outflow into securities vs. competitor’s approach, risking near-term FCF.
-1.00%
Both yoy lines are negative, with MRVL at -100.00%. Martin Whitman suspects an environment prompting fewer sales or fewer maturities within the niche.
-130.95%
We reduce yoy other investing while MRVL is 96.18%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
348.32%
We have mild expansions while MRVL is negative at -32.65%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
100.00%
Debt repayment growth of 100.00% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
103.51%
Stock issuance far above MRVL's 70.21%. Michael Burry flags a significant dilution risk vs. competitor’s approach unless ROI is very high.
13.46%
Buyback growth of 13.46% while MRVL is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.